Problem: Pharmaceutical CROs (Clinical or Contract Research Organisations) face rising costs and intense competition, making speed with efficiency critical. It is known that delays are due to unsynchronised workflows, but a solution remains elusive despite best efforts.  Solution: The key to solving this issue is in recognising that CRD (Clinical Research Data), the constrained resource, in the existing system, has to multitask across past, present and future tasks simultaneously. So, the solution involves designing a structured approach to decouple CRD from conflicting tasks.  Benefits: The new way of working can reduce study observations by 40%-50%, improve turnaround by 25%-35%, enhance regulatory compliance, strengthen CRO-client partnerships, boost reputation and business growth.

Key Takeaways

How can Indian CROs reduce the number of observations and deviations observed during the studies by 40%-50% and generate the final integrated report 25%-35% faster with the same resources while protecting the quality of reports? Find out

Agile CROs can fly high

Download PDF

Explore how Agile CROs are reshaping pharmaceutical clinical trials with speed, quality, and cost-effectiveness, amid rising global demands and regulatory challenges.